Malaysia’s Pharmaniaga eyes halal-certified insulin production in Uzbekistan 

Malaysian pharmaceutical giant Pharmaniaga Berhad is looking to leverage opportunities to cooperate in pharmaceutical production within Uzbekistan. 

The Malaysian company has expressed interest in launching the production of halal-certified insulin at the Tashkent Pharma Park pharmaceutical cluster in collaboration with Uzbek companies, news agency Daryo reported. 

Pharmaniaga Berhad is working with Uzbekistan’s Agency for the Development of the Pharmaceutical Industry to explore the joint production of various pharmaceutical products in the country. 

Pharmaniaga will transfer technologies from Malaysia to support insulin production in compliance with halal standards using Uzbekistan’s existing pharmaceutical infrastructure during the initial phase. Future stages will involve additional investment to expand and develop the business, the report added. 

Pharmaniaga Berhad operates four pharmaceutical manufacturing plants in Malaysia, three factories in Indonesia, and a research centre. It is also engaged in logistics, medical product supply, and pharmaceutical sales and marketing.

The company supplies halal-certified insulin to public health institutions under government procurement contracts and has implemented a system for free distribution of insulin products across Malaysia, Zulkifli Jafar, Pharmaniaga Berhad’s executive director said.